The Macrophage migration inhibitory factor is a vital player in Pan-Cancer by functioning as a M0 Macrophage biomarker
Article in International Immunopharmacology (May 2024)
The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.
Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities
Article in International Journal of Molecular Sciences (April 2024)
The human MIF polymorphism CATT7 enhances pro‐inflammatory macrophage polarization in a clinically relevant model of allergic airway inflammation
Article in The FASEB Journal (March 2024)